{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:37:34Z","timestamp":1793659054632,"version":"4.5.1"},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T00:00:00Z","timestamp":1476230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005897","name":"Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie et de Pathologie Sexuellement Transmissible","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005897","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation Ren\u00e9 Touraine pour la Dermatologie"},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Philantropic crowdfunding"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0005030","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T17:33:09Z","timestamp":1476293589000},"page":"e0005030","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":93,"title":["Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model"],"prefix":"10.1371","volume":"10","author":[{"given":"Charlotte","family":"Bernigaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lespine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig Serge","family":"Aho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Dreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Sutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lilin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Botterel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chosidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,10,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/jid.2013.446","article-title":"The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions","volume":"134","author":"RJ Hay","year":"2014","journal-title":"J Invest Dermatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2471\/BLT.07.047308","article-title":"Epidermal parasitic skin diseases: a neglected category of poverty-associated plagues","volume":"87","author":"H Feldmeier","year":"2009","journal-title":"Bull World Health Organ"},{"key":"ref3","unstructured":"WHO. Scabies. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/neglected_diseases\/diseases\/scabies\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/neglected_diseases\/diseases\/scabies\/en\/<\/ext-link>"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e2167","DOI":"10.1371\/journal.pntd.0002167","article-title":"Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies","volume":"7","author":"D Engelman","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S1473-3099(15)00132-2","article-title":"Prevalence of scabies and impetigo worldwide: a systematic review","volume":"15","author":"L Romani","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref6","first-page":"428","article-title":"Increasing incidence of scabies in France, 1999\u20132010, and public health implications","volume":"139","author":"D Bitar","year":"2012","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ologie"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1440-0960.2011.00806.x","article-title":"Skin disease in the first two years of life in Aboriginal children in East Arnhem Land","volume":"52","author":"E McMeniman","year":"2011","journal-title":"Australas J Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5694\/j.1326-5377.2001.tb143394.x","article-title":"Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life","volume":"174","author":"AV White","year":"2001","journal-title":"Med J Aust"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00001432-200304000-00001","article-title":"Pyoderma and scabies: a benign association?","volume":"16","author":"RJ Hay","year":"2003","journal-title":"Curr Opin Infect Dis"},{"key":"ref10","first-page":"34","article-title":"Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin","volume":"83","author":"G Lawrence","year":"2005","journal-title":"Bull World Health Organ"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1017\/S0950268814002143","article-title":"Scabies outbreaks in residential care homes: factors associated with late recognition, burden and impact. A mixed methods study in England","volume":"143","author":"KA Hewitt","year":"2015","journal-title":"Epidemiol Infect"},{"key":"ref12","article-title":"Retrospective analysis of institutional scabies outbreaks from 1984 to 2013: lessons learned and moving forward [e-pub ahead of print]","author":"KE Mounsey","journal-title":"Epidemiol Infect"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/bjd.14226","article-title":"Prevalences of scabies and pediculosis corporis among homeless in the Paris region: results from 2 random cross-sectional surveys (HYTPEAC study)","volume":"174","author":"A Arnaud","year":"2016","journal-title":"Br J Dermatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1086\/516518","article-title":"Is crusted (Norwegian) scabies a marker of adult T cell leukemia\/lymphoma in human T lymphotropic virus type I-seropositive patients?","volume":"176","author":"P del Giudice","year":"1997","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jinf.2004.08.033","article-title":"Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature","volume":"50","author":"LJ Roberts","year":"2005","journal-title":"J Infect"},{"key":"ref16","first-page":"1718","article-title":"Clinical practices. Scabies","volume":"354","author":"O Chosidow","year":"2006","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMct0910329","article-title":"Permethrin and ivermectin for scabies","volume":"362","author":"BJ Currie","year":"2010","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","article-title":"Mass Drug Administration for Scabies Control in a Population with Endemic Disease","volume":"373","author":"L Romani","year":"2015","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1201-9712(98)90118-7","article-title":"Ivermectin for <italic>Sarcoptes scabiei<\/italic> hyperinfestation","volume":"2","author":"SE Huffam","year":"1998","journal-title":"Int J Infect Dis"},{"key":"ref20","first-page":"CD000320","article-title":"Interventions for treating scabies","author":"M Strong","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4269\/ajtmh.2006.74.649","article-title":"PCR-based assay to survey for knockdown resistance to pyrethroid acaricides in human scabies mites (<italic>Sarcoptes scabiei var hominis<\/italic>)","volume":"74","author":"C Pasay","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1086\/421776","article-title":"First documentation of <italic>in vivo<\/italic> and <italic>in vitro<\/italic> ivermectin resistance in <italic>Sarcoptes scabiei<\/italic>","volume":"39","author":"BJ Currie","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/archdermatol.2009.125","article-title":"Longitudinal evidence of increasing <italic>in vitro<\/italic> tolerance of scabies mites to ivermectin in scabies-endemic communities","volume":"145","author":"KE Mounsey","year":"2009","journal-title":"Arch Dermatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1056\/NEJMe1211124","article-title":"Topical ivermectin\u2014a step toward making head lice dead lice?","volume":"367","author":"O Chosidow","year":"2012","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa0905471","article-title":"Oral ivermectin <italic>versus<\/italic> malathion lotion for difficult-to-treat head lice","volume":"362","author":"O Chosidow","year":"2010","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1056\/NEJMc1215548","article-title":"Topical ivermectin lotion for head lice","volume":"368","author":"IF Burgess","year":"2013","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/bjd.13408","article-title":"Superiority of ivermectin 1% cream over metronidazole 0\u00b775% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial","volume":"172","author":"A Taieb","year":"2015","journal-title":"Br J Dermatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e0004389","DOI":"10.1371\/journal.pntd.0004389","article-title":"Prospects for Moxidectin as a New Oral Treatment for Human Scabies","volume":"10","author":"KE Mounsey","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpddr.2012.04.001","article-title":"Moxidectin and the avermectins: Consanguinity but not identity","volume":"2","author":"R Prichard","year":"2012","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref30","first-page":"545","article-title":"Plasma profile study of moxidectin in a cow and its suckling calf","volume":"27","author":"M Alvinerie","year":"1996","journal-title":"Vet Res"},{"key":"ref31","first-page":"113","article-title":"The pharmacokinetics of moxidectin after oral and subcutaneous administration to sheep","volume":"29","author":"M Alvinerie","year":"1998","journal-title":"Vet Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2885.1999.00222.x","article-title":"Moxidectin in cattle: correlation between plasma and target tissues disposition","volume":"22","author":"A Lifschitz","year":"1999","journal-title":"J Vet Pharmacol Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1371\/journal.pntd.0000756","article-title":"A tractable experimental model for study of human and animal scabies","volume":"4","author":"K Mounsey","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research","volume":"8","author":"C Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0304-4017(03)00098-0","article-title":"Detection of antibodies in sera of weaned pigs after contact infection with <italic>Sarcoptes scabiei<\/italic> var. <italic>suis<\/italic> and after treatment with an antiparasitic agent by three different indirect ELISAs","volume":"114","author":"E Kessler","year":"2003","journal-title":"Vet Parasitol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vetpar.2004.11.028","article-title":"Influence of the route of administration on efficacy and tissue distribution of ivermectin in goat","volume":"128","author":"A Lespine","year":"2005","journal-title":"Vet Parasitol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.vetpar.2005.11.009","article-title":"World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for evaluating the efficacy of acaricides against (mange and itch) mites on ruminants","volume":"136","author":"J Vercruysse","year":"2006","journal-title":"Vet Parasitol"},{"key":"ref38","article-title":"Negative Binomial Regression","author":"JM Hilbe","year":"2011"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.0006-341X.2000.00645.x","article-title":"A note on robust variance estimation for cluster-correlated data","volume":"56","author":"RL Williams","year":"2000","journal-title":"Biometrics"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.vetpar.2006.04.001","article-title":"Comparison of scratching behaviour of growing pigs with sarcoptic mange before and after treatment, employing two distinct approaches","volume":"140","author":"M Loewenstein","year":"2006","journal-title":"Vet Parasitol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fnhum.2015.00057","article-title":"Contagious itch: what we know and what we would like to know","volume":"9","author":"C Schut","year":"2015","journal-title":"Front Hum Neurosci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/jee\/83.4.1439","article-title":"Pruritus and behavior of pigs infested by itch mites, <italic>Sarcoptes scabiei<\/italic> (Acari: Sarcoptidae)","volume":"83","author":"DP Davis","year":"1990","journal-title":"J Econ Entomol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01839011","article-title":"The distribution and some pharmacokinetic parameters of ivermectin in pigs","volume":"16","author":"EW Scott","year":"1992","journal-title":"Vet Res Commun"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2885.2002.00400.x","article-title":"The effects of body composition on the pharmacokinetics of subcutaneously injected ivermectin and moxidectin in pigs","volume":"25","author":"J Craven","year":"2002","journal-title":"J Vet Pharmacol Ther"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2885.1987.tb00097.x","article-title":"The pharmacokinetics of ivermectin after oral and subcutaneous administration to sheep and horses","volume":"10","author":"SE Marriner","year":"1987","journal-title":"J Vet Pharmacol Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2885.1997.00825.x","article-title":"Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle","volume":"20","author":"C Lanusse","year":"1997","journal-title":"J Vet Pharmacol Ther"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2885.2003.00526.x","article-title":"The comparative serum disposition kinetics of subcutaneous administration of doramectin, ivermectin and moxidectin in the Australian Merino sheep","volume":"26","author":"S Barber","year":"2003","journal-title":"J Vet Pharmacol Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bdd.572","article-title":"Comparison of the pharmacokinetics of moxidectin and ivermectin after oral administration to beagle dogs","volume":"28","author":"SI Al-Azzam","year":"2007","journal-title":"Biopharm Drug Dispos"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/009127002401382731","article-title":"Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects","volume":"42","author":"CA Guzzo","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1177\/0091270003257456","article-title":"The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans","volume":"43","author":"MM Cotreau","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejps.2006.10.004","article-title":"Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship","volume":"30","author":"A Lespine","year":"2007","journal-title":"Eur J Pharm Sci"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"24248","DOI":"10.1016\/S0021-9258(18)35757-0","article-title":"Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone","volume":"267","author":"K Ueda","year":"1992","journal-title":"J Biol Chem"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.vetpar.2012.07.011","article-title":"Dexamethasone treatment interferes with the pharmacokinetics of ivermectin in young cattle","volume":"190","author":"M Areskog","year":"2012","journal-title":"Vet Parasitol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/bjd.14092","article-title":"Genetically engineered pigs as investigative and translational models in dermatology","volume":"174","author":"MR Schneider","year":"2016","journal-title":"Br J Dermatol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1524-475x.2001.00066.x","article-title":"The pig as a model for human wound healing","volume":"9","author":"TP Sullivan","year":"2001","journal-title":"Wound Repair Regen"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molimm.2014.10.023","article-title":"The immunology of the porcine skin and its value as a model for human skin","volume":"66","author":"A Summerfield","year":"2015","journal-title":"Mol Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tim.2011.11.002","article-title":"The pig: a model for human infectious diseases","volume":"20","author":"F Meurens","year":"2012","journal-title":"Trends Microbiol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000029928","article-title":"The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations\u2014an overview","volume":"13","author":"GA Simon","year":"2000","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00000372-198606000-00018","article-title":"Similar epidermal changes in hyperkeratotic scabies of humans and pigs","volume":"8","author":"DJ Van Neste","year":"1986","journal-title":"Am J Dermatopathol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"e2897","DOI":"10.1371\/journal.pntd.0002897","article-title":"Scabies Mites Alter the Skin Microbiome and Promote Growth of Opportunistic Pathogens in a Porcine Model","volume":"8","author":"PM Swe","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"e0004151","DOI":"10.1371\/journal.pntd.0004151","article-title":"Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community","volume":"9","author":"TM Kearns","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref62","first-page":"9","article-title":"Therapeutic failure in scabies: An observational study","volume":"143","author":"B De Sainte Marie","year":"2016","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ologie"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.dmpk.2015.07.004","article-title":"Mechanism for transport of ivermectin to the <italic>stratum corneum<\/italic> in rats","volume":"30","author":"A Miyajima","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vetpar.2016.04.003","article-title":"Efficacy and productive performance of moxidectin in feedlot calves infected with nematodes resistant to ivermectin","volume":"223","author":"LE Fazzio","year":"2016","journal-title":"Vet Parasitol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"e1883","DOI":"10.1371\/journal.pntd.0001883","article-title":"Relative neurotoxicity of ivermectin and moxidectin in Mdr1ab (-\/-) mice and effects on mammalian GABA(A) channel activity","volume":"6","author":"C M\u00e9nez","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2460\/ajvr.2000.61.482","article-title":"Safety of moxidectin in avermectin-sensitive collies","volume":"61","author":"AJ Paul","year":"2000","journal-title":"Am J Vet Res"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1128\/AAC.00311-11","article-title":"Excretion of moxidectin into breast milk and pharmacokinetics in healthy lactating women","volume":"55","author":"JM Korth-Bradley","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.1371\/journal.pntd.0000444","article-title":"Community management of endemic scabies in remote aboriginal communities of northern Australia: low treatment uptake and high ongoing acquisition","volume":"3","author":"S La Vincente","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijantimicag.2007.08.023","article-title":"Ivermectin: 25 years and still going strong","volume":"31","author":"S Omura","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"e2953","DOI":"10.1371\/journal.pntd.0002953","article-title":"A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in <italic>Onchocerca volvulus<\/italic> infection","volume":"8","author":"K Awadzi","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref71","unstructured":"Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection -ClinicalTrials.gov. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00790998\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00790998<\/ext-link>"},{"key":"ref72","unstructured":"WHO. TDR. New funding for continued development of onchocerciasis treatment moxidectin [cited 18 Jan 2016]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tdr\/news\/2015\/moxi-treatmt-funding\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/tdr\/news\/2015\/moxi-treatmt-funding\/en\/<\/ext-link>"},{"key":"ref73","unstructured":"Medicine Development. Addressing scabies, the neglected of neglected disease [cited 18 June 2016]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.medicinesdevelopment.com\/news-posts\/addressing-scabies-the-neglected-of-neglected-disease\/\" xlink:type=\"simple\">http:\/\/www.medicinesdevelopment.com\/news-posts\/addressing-scabies-the-neglected-of-neglected-disease\/<\/ext-link>"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0005030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T06:09:39Z","timestamp":1657433379000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0005030"}},"subtitle":[],"editor":[{"given":"Joseph M.","family":"Vinetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,12]]},"references-count":73,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0005030","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,12]]}}}